CAVE CREEK, AZ , Sept. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, announced today the appointment of Dustin Sullivan as the Company’s Chief Operating Officer. Mr. Sullivan previously served as Vice President of Business Development at Impulse Health, LLC.
“Dustin adds tremendous strength to our team and in the short period of time has generated significant value for our operations,” said Endexx Chief Executive Officer Todd Davis. Mr. Davis added, “Earlier in the year we partnered with Impulse Health for our GorillaTek™ technology and have witnessed firsthand, Dustin’s ability to drive operational excellence –from his relationships within the industry to making introductions to key retail partners who will be vital to our growth. I am confident he will effectively build long-term business relationships as well as manage the trajectory of our growth from end-to-end.”
As Chief Operating Officer, Dustin will be responsible for leading Endexx’s day-to-day operations on all of its consumable product lines as well as the Company’s technology products - m3hub and Gorilla-Tek™. He will also oversee and manage internal strategy and decisions as it relates to educating, introducing, and marketing the Company’s proprietary and best-in-class inventory control and automated dispensing device. His category specialties are specific to the CBD market going forward given his knowledge in the space and deep relationships within the industry. At Impulse Health, Mr. Sullivan worked directly with drugstores, grocery stores and mass merchant retailers stores to launch and grow a variety of healthcare brands and products. This included building complete product lifecycle plans including packaging, production, distribution, sales and marketing. Previously Mr. Sullivan spent over 15 years with Walgreens, which included director and category management responsibilities driving key customer focused strategies for general merchandise and healthcare divisions. In these roles he developed strategy and growth plans across a variety of businesses ranging from general merchandise to complex, compliance-based healthcare categories.
Dustin Sullivan commented, “I’m excited to join Endexx and look forward to working on a variety of new and innovative retail solutions. In my prior retail and sales experiences, customer insights always took priority in our decision-making process. This customer-focused thinking will continue to be at the core of Endexx’s growing consumer products and retail technology divisions.”
About Endexx
Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 – the m3hub and the AutoSpense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical-grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The AutoSpense™ is a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, AutoSpense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com,www.endexx.com and www.phytobites.com.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.